linafexor   Click here for help

GtoPdb Ligand ID: 14569

Synonyms: CS-0159 | CS0159
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Linafexor (CS0159) is a non-bile-acid agonist of the farnesoid X receptor (FXR) [1]. It is designed to mimic the pulsatile nature of physiological bile acid dynamics as an approach to reduce the risk of toxicity arising from sustained drug delivery.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 84.75
Molecular weight 571.43
XLogP 4.9
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CC(=C(C(=C1)Cl)C2=NOC(=C2COC3C[C@@H]4CC[C@H](C3)N4C5=CC(=C(C=C5)C6=NOC(=O)N6)F)C7CC7)Cl
Isomeric SMILES C1C[C@H]2CC(C[C@@H]1N2C3=CC(=C(C=C3)C4=NOC(=O)N4)F)OCC5=C(ON=C5C6=C(C=CC=C6Cl)Cl)C7CC7
InChI InChI=1S/C28H25Cl2FN4O4/c29-21-2-1-3-22(30)24(21)25-20(26(38-33-25)14-4-5-14)13-37-18-10-15-6-7-16(11-18)35(15)17-8-9-19(23(31)12-17)27-32-28(36)39-34-27/h1-3,8-9,12,14-16,18H,4-7,10-11,13H2,(H,32,34,36)/t15-,16+,18?
InChI Key CEEANZUSISGCJL-BYICEURKSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
In cell-based FXR transcriptional activation assays linafexor exhibits comparable potency to tropifexor and is ~800-fold more potent than obeticholic acid [1].
Selectivity at nuclear hormone receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Farnesoid X receptor Hs Agonist Agonist 8.4 pEC50 - 1
⤷ pEC50 8.4 (EC50 3.78x10-9 M) [1]